Tekla Life Sciences Investors (NYSE:HQL)
| 13.74 BATS BZX Real-Time Price As of 9:43am ET |  +0.12 / +0.88%Today’s Change | 13.03 Today|||52-Week Range 17.14 | -3.31% Year-to-Date |
Latest HQL News | Press Releases
No recent news for Tekla Life Sciences Investors.
Today’s Trading
| Previous close | 13.62 |
| Today’s open | 13.75 |
| Day’s range | 13.72 - 13.75 |
| Volume | 117,111 |
| Average volume (3 months) | 101,227 |
| Market cap | $396.0M |
Data as of 9:43am ET, 03/27/2023
Growth & Valuation
| Earnings growth (last year) | -253.14% |
| Earnings growth (this year) | -- |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -29.23% |
| P/E ratio | -- |
| Price/Sales | 11.01 |
| Price/Book | 1.02 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| DFPFlaherty & Crumrine ... | +0.01 | +0.06% |
| BFZBlackRock California... | -0.02 | -0.18% |
| ETOEaton Vance Tax-Adva... | +0.03 | +0.14% |
| KTFDWS Municipal Income... | +0.02 | +0.23% |
Data as of 3:59pm ET, 03/24/2023
Financials
| Next reporting date | -- |
| EPS forecast (this quarter) | -- |
| Annual revenue (last year) | $31.9M |
| Annual profit (last year) | -$104.6M |
| Net profit margin | -328.30% |
Profile
Sector Miscellaneous |
Industry Investment Trusts/Mutual Funds |
No executives to display |
Corporate headquarters Boston, Massachusetts |
Forecasts
